Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Hokkaido Mitsui Chemicals to Produce Anti-Cancer Drug Ingredient From Plant Cell Culture

Filed Under: Innovation, Pharma Tagged With: , , , , , , , , ,

Mitsui Chemicals Inc. (TYO:4183) group plans to develop a plant cell culture technology for efficiently producing an ingredient in the…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Acquire Meiji Seika Pharma's Agrochemical Business
Mitsui Chemicals to Acquire Meiji Seika Pharma's…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…
Ube Industries Readies for Launch Into Biopharmaceuticals
Ube Industries Readies for Launch Into Biopharmaceuticals